Format

Send to

Choose Destination
Peptides. 2014 Jan;51:131-8. doi: 10.1016/j.peptides.2013.10.009. Epub 2013 Nov 22.

Increased serum chemerin level promotes cellular invasiveness in gastric cancer: a clinical and experimental study.

Author information

1
Department of Surgery, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong; Seventeenth Department of Plastic Surgery, Plastic Surgery Hospital (Institute), Chinese Academy of Medical Sciences & Peking Union Medical College, China.
2
Institute of Digestive Disease and State Key Laboratory of Digestive Disease, Department of Medicine & Therapeutics and LKS Institute of Health Sciences, The Chinese University of Hong Kong, Hong Kong.
3
Department of Anaesthesia & Intensive Care, The Chinese University of Hong Kong, Hong Kong.
4
Department of Anatomical & Cellular Pathology, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong.
5
Department of Surgery, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong.
6
Department of Surgery, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong; Institute of Digestive Disease and State Key Laboratory of Digestive Disease, Department of Medicine & Therapeutics and LKS Institute of Health Sciences, The Chinese University of Hong Kong, Hong Kong. Electronic address: endersng@surgery.cuhk.edu.hk.

Abstract

This study sought to determine the serum levels of chemerin in gastric cancer patients and healthy subjects and to investigate the biological effect of chemerin on gastric cancer cells. Serum chemerin level of 36 gastric cancer patients and 40 healthy subjects was measured by enzyme-linked immunosorbent assay. AGS and MKN28 cells were treated with recombinant human chemerin, MAPKs phosphorylation was then measured. Chemerin were added to culture medium of AGS and MKN28 in the absence or presence of MAPK inhibitors, VEGF, MMP-7, IL-6 and cell invasiveness assay were then performed. Serum level of chemerin was significantly higher in gastric cancer patients than healthy subjects (P<0.01). The elevation of serum chemerin level was associated with advanced clinical stages and nonintestinal type of gastric cancer. Chemerin increased invasiveness of gastric cancer cells. Chemerin induced phosphorylation of p38 and ERK1/2 MAPKs and upregulated VEGF, MMP-7 and IL-6. Inhibition of ERK1/2 phosphorylation abolished the upregulation of VEGF, MMP-7 and IL-6 and the pro-invasive effect of chemerin. This study demonstrates a novel action of chemerin in gastric carcinogenesis.

KEYWORDS:

(3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide; Adipokine; Chemerin; ERK1/2; Gastric cancer; IL; Invasiveness; MAPK; MMP; MTT; VEGF; extracellular signal-regulated protein kinases 1 and 2; interleukin; matrix metalloproteinase; mitogen-activated protein kinase; vascular endothelial growth factor

PMID:
24274970
DOI:
10.1016/j.peptides.2013.10.009
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center